title: Smoking cessation and development of respiratory health in smokers screened with normal spirometry.
abstract: BACKGROUND
  Case-finding of chronic obstructive pulmonary disease (COPD) using spirometry may deter people with normal lung function from stopping smoking. The objective of this study was to observe the percentage of smokers screened with normal lung function that quit smoking.
  
  
  METHODS
  As part of a study on early detection of COPD, 518 smokers were screened with normal lung function (post-bronchodilator FEV(1)/FVC ≥ 70%). They were invited for a follow-up measurement after an average of 2.4 years. Non-smoking was validated by carbon monoxide (<10 ppm), and respiratory health related quality of life was measured with the Clinical COPD Questionnaire (CCQ).
  
  
  RESULTS
  A total of 255 participants were followed up (49%). The point prevalence rate of non-smoking at follow-up was 18% (N = 47), and 9% assuming that all non-respondents were smokers. This rate was not lower than the expected rate of quitting in the Dutch population (8-9%) and primary "care as usual" in smokers screened with abnormal lung function (10%; p > 0.05 for all comparisons). The average decline in post-bronchodilator FEV(1) was 26 mL/year, which was unrelated to smoking status at follow-up. Non-smokers showed a clinically meaningful and statistically significant (p < 0.001) improvement in CCQ respiratory symptoms (-0.96) and total score (-0.51).
  
  
  CONCLUSIONS
  Our results do not suggest that early detection of airflow limitation to motivate smoking cessation reduces the rate of quitting in smokers shown to have normal lung function. Such smokers should be advised to quit smoking on the grounds that they are likely to improve their respiratory health in the short term and reduce their risk for smoking related diseases in the long term.
authors.affiliation: Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, P.O. Box 616, 6200 MD Maastricht, The Netherlands. d.kotz@hag.unimaas.nl
authors.forename: Daniel
authors.initials: D
authors.lastname: Kotz
authors.forename: Geertjan
authors.initials: G
authors.lastname: Wesseling
authors.forename: Paul
authors.initials: P
authors.lastname: Aveyard
authors.forename: Onno C P
authors.initials: OC
authors.lastname: van Schayck
mesh_terms: D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D029424:Pulmonary Disease, Chronic Obstructive / Q000503:physiopathology / Q000517:prevention & control / Q000523:psychology*; D012129:Respiratory Function Tests / Q000523:psychology; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology*; D016540:Smoking Cessation / Q000523:psychology / Q000706:statistics & numerical data*; D013147:Spirometry / Q000523:psychology; D011795:Surveys and Questionnaires